CYCLOPHOSPHAMIDE CYSTITIS AND BLADDER-CANCER - HYPOTHESIS

[1] CARCINOMA OF BLADDER COMPLICATING CYCLOPHOSPHAMIDE THERAPY [J]. BRITISH JOURNAL OF UROLOGY, 1975, 47 (04): : 413 - 418

[2] EFFECTS OF CYCLOPHOSPHAMIDE TREATMENT ON EPITHELIUM AND STROMA OF URINARY-BLADDER [J]. EUROPEAN JOURNAL OF CANCER, 1978, 14 (10) : 1029 - +

[3] CADMAN E, 1977, CANCER COMPREHENSIVE, V5, P59

[4] CYCLOPHOSPHAMIDE CYSTITIS - IDENTIFICATION OF ACROLEIN AS THE CAUSATIVE AGENT [J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (13) : 2045 - 2049

[5] KOSS LG, 1967, LAB INVEST, V16, P44

[6] KOSS LG, 1970, J NATL CANCER I, V44, P1195

[7] LOCHER GW, 1970, INVEST UROL, V8, P116

[8] PURI HC, 1977, LANCET, V1, P1306

[9] RICHTSMEIER AJ, 1975, NEW ENGL J MED, V293, P1045

[10] CARCINOMA OF URINARY-BLADDER IN PATIENTS RECEIVING CYCLOPHOSPHAMIDE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (06) : 271 - 273

[1] CARCINOMA OF BLADDER COMPLICATING CYCLOPHOSPHAMIDE THERAPY [J]. BRITISH JOURNAL OF UROLOGY, 1975, 47 (04): : 413 - 418

[2] EFFECTS OF CYCLOPHOSPHAMIDE TREATMENT ON EPITHELIUM AND STROMA OF URINARY-BLADDER [J]. EUROPEAN JOURNAL OF CANCER, 1978, 14 (10) : 1029 - +

[3] CADMAN E, 1977, CANCER COMPREHENSIVE, V5, P59

[4] CYCLOPHOSPHAMIDE CYSTITIS - IDENTIFICATION OF ACROLEIN AS THE CAUSATIVE AGENT [J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (13) : 2045 - 2049

[5] KOSS LG, 1967, LAB INVEST, V16, P44

[6] KOSS LG, 1970, J NATL CANCER I, V44, P1195

[7] LOCHER GW, 1970, INVEST UROL, V8, P116

[8] PURI HC, 1977, LANCET, V1, P1306

[9] RICHTSMEIER AJ, 1975, NEW ENGL J MED, V293, P1045

[10] CARCINOMA OF URINARY-BLADDER IN PATIENTS RECEIVING CYCLOPHOSPHAMIDE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (06) : 271 - 273